Ralimetinib (LY2228820) dimesylate
Product Specifications
CAS Number
862507-23-1
Target
P38 MAPK
Applications
MAPK
Smiles
CC (C) (C) CN1C2=C (C=CC (=N2) C3=C (N=C (N3) C (C) (C) C) C4=CC=C (C=C4) F) N=C1N.CS (=O) (=O) O.CS (=O) (=O) O
Molecular Formula
C24H29FN6.2CH4O3S
Additionnal Information
Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400003-100 1x 100 µL
CD45RO (UCHL-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740630-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880029-100 1x 100 µL
Fibronectin (TV-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 